Literature DB >> 1342109

Use of MAC-ELISA for evaluation of yellow fever vaccination.

R M Nogueira1, H G Schatzmayr, M P Miagostovich, S M Cavalcanti, R de Carvalho.   

Abstract

An evaluation of the IgM antibody immune response against yellow fever using strain 17D was carried out by MAC-ELISA and PRNT. The results showed an agreement of 97% between both tests and the authors conclude that MAC-ELISA can be used as a specific and sensitive assay to replace the PRNT for detecting yellow fever antibodies in human sera, after vaccination programs.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1342109     DOI： 10.1590/s0036-46651992000500012

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN： 0036-4665            Impact factor:   1.846


  2 in total

1.  Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination.

Authors:  Katherine B Gibney; Srilatha Edupuganti; Amanda J Panella; Olga I Kosoy; Mark J Delorey; Robert S Lanciotti; Mark J Mulligan; Marc Fischer; J Erin Staples
Journal:  Am J Trop Med Hyg       Date:  2012-10-29       Impact factor: 2.345

2.  Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil.

Authors:  Andréa Barbosa de Melo; Maria da Paz C da Silva; Maria Cecília F Magalhães; Laura Helena Vega Gonzales Gil; Eduardo M Freese de Carvalho; Ulisses M Braga-Neto; Giovani Rota Bertani; Ernesto T A Marques; Marli Tenório Cordeiro
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.